MJ Hudson advises 4BIO Capital on the establishment of a closed-ended venture fund

MJ Hudson has advised 4BIO Partners LLP (4BIO) on the establishment of a closed-ended venture capital fund. 4BIO is a London-based investment firm that invests in venture capital and public equities in life sciences focussing on gene, cell and RNA-based therapies.

Browser Compatibility Notice

Welcome to MJ Hudson. Please note, this website will not function as intended on Internet Explorer.

For the full experience, we recommended viewing this website on a modern browser, such as Edge, Google Chrome or Mozilla Firefox.

Share this page using the options below